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Abstract
Background: Mucin hypersecretion and mucus plugging in the airways are characteristic features
of chronic respiratory diseases like cystic fibrosis (CF) and contribute to morbidity and mortality.
In CF, Pseudomonas aeruginosa superinfections in the lung exacerbate inflammation and alter mucus
properties. There is increasing evidence that n-3 polyunsaturated fatty acids (PUFAs) exhibit anti-
inflammatory properties in many inflammatory diseases while n-6 PUFA arachidonic acid (AA)
favors inflammatory mediators such as eicosanoids prostaglandin E2 (PGE2) and leukotriene B4
(LTB4) that may enhance inflammatory reactions. This suggests that n-3 PUFAs may have a
protective effect against mucus over-production in airway diseases. Therefore, we hypothesized
that n-3 PUFAs may downregulate mucins expression.
Methods: We designed an absolute real-time PCR assay to assess the effect of a 5-week diet
enriched either with n-3 or n-6 PUFAs on the expression of large mucins in the lungs of mice
infected by P. aeruginosa.
Results: Dietary fatty acids did not influence mucin gene expression in healthy mice. Lung infection
induced an increase of the secreted gel-forming mucin Muc5b and a decrease of the membrane
bound mucin Muc4. These deregulations are modulated by dietary fatty acids with a suppressive
effect of n-3 PUFAs on mucin (increase of Muc5b from 19-fold up to 3.6 × 105-fold for the n-3
PUFAs treated group and the control groups, respectively, 4 days post-infection and decrease of
Muc4 from 15-fold up to 3.2 × 104-fold for the control and the n-3 PUFAs treated groups,
respectively, 4 days post-infection).
Conclusion: Our data suggest that n-3 PUFAs enriched diet represents an inexpensive strategy
to prevent or treat mucin overproduction in pulmonary bacterial colonization.
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Background
Pseudomonas aeruginosa is an opportunistic Gram-negative
pathogen known for its environmental versatility and
ability to cause diseases in susceptible individuals. P. aer-
uginosa is an inhabitant of soil, water and vegetation but,
unlike many environmental bacteria, can cause urinary,
respiratory, and digestive tract infections usually restricted
to hospitalized patients with predisposing conditions
(device related infections, mechanical ventilation). More-
over, P. aeruginosa respiratory tract chronic infections are
common in cystic fibrosis (CF) and other chronic lung
conditions generating excessive inflammatory response
leading to airway obstruction and structural lung damage
[1].
Pseudomonas  superinfections in CF, as well as chronic
obstructive pulmonary disease (COPD), are multifactorial
involving innate host immunity, pathogen characteristics
and mucus properties. Chronic inflammatory diseases are
mainly characterized by an inappropriate production of
inflammatory mediators and chronic inflammation,
which is associated with tissue damage and organ dys-
function. There is evidence that n-3 polyunsaturated fatty
acids (PUFAs) exhibit anti-inflammatory properties in
many inflammatory diseases while n-6 PUFA arachidonic
acid (AA) favors inflammatory mediators such as eicosa-
noids prostaglandin E2 (PGE2) and leukotriene B4 (LTB4)
that may enhance inflammatory reactions. Experimental
data and clinical studies suggest that n-3 PUFAs represent
potential therapeutic agents for inflammatory diseases
(reviewed by Mori and Beilin [2]; James et al. [3]). For
example, Shahar et al. reported that dietary intake of n-3
fatty acids and fish consumption play a protective effect in
COPD [4]. In fact, n-3 PUFAs could improve not only
inflammation but also diminish mucosal damage [5].
Concerning CF, Freedman et al. showed that a membrane
lipid imbalance exists in both Cftr-/- mice and in subjects
with cystic fibrosis [6-8]. This imbalance may play a cru-
cial role in the pathogenesis of CF and could be corrected
by oral administration of docosahexaenoic acid (DHA).
One important factor in the morbidity and mortality of
chronic airway diseases is the overproduction of mucus
with altered rheologic properties (for review, see [9]),
which may influence the first step of pathogen adhesion.
For example, gland ducts of the airway epithelium
become occluded with mucus during the first months in
the CF fetus [10]. Mucins are heavily O-glycosylated pro-
teins found in the mucus layer and responsible for its
physical properties. These complex large molecules trap
bacteria in the lung, and the ciliary beating draws the
mucus layer up to the pharynx where normally it is swal-
lowed (for reviews, see [11,12]). Mucins are usually sub-
divided into two families. The first one is made of large
monomeric mucins, which are located primarily, but not
exclusively, at the cell surface. The other one is made of
the five, large secreted gel-forming mucins MUC6, MUC2,
MUC5AC,  MUC5B  and  MUC19, which are conserved
between human and mouse [13-15] and form oligomeric
structures [9,16,17]. Among the identified mucins, the
large anchored-mucin MUC4 and the two large gel-form-
ing mucins MUC5B and MUC5AC seem highly expressed
in normal and/or abnormal human lung while MUC2 is
almost not detectable [18]. At the cellular level, MUC5AC
is expressed in the goblet cells of main bronchi and bron-
chioles and MUC5B is expressed in bronchiolar epithe-
lium and in submucosal gland epithelium while MUC4
transcripts are detected in the epithelium of main bronchi
and bronchioles [19-21]. While many studies have
focused on gene regulation of both MUC2 and MUC5AC
using mainly airway cell cultures and explants, regulation
of  MUC4  and  MUC5B  in airway diseases have been
ignored to date.
In this study, we hypothesized that dietary intakes of n-3
PUFAs decrease mucin production in chronic airway dis-
eases that likely decreases the mucus visco-elasticity and,
on the other hand, that a diet enriched in n-6 PUFAs exac-
erbated mucin expression. We determined the mucin
expression pattern in lung of healthy wild-type mice and
then  in vivo mucin regulation of Pseudomonas-infected
mice that were fed for 5 weeks with a diet enriched in
either n-3 PUFAs or n-6 PUFAs compared to a control
rodent diet with equal fat content.
Methods
Mice
Five-week-old male C57BL/6 mice were purchased from
Charles River (France) and housed five per cage in filter-
capped cages with hardwood bedding. Cages are placed
into a ventilated cabinet in a quiet room at the University
of Lille on a 12:12 hour light/dark cycle and were kept at
a constant room temperature (24°C). Animals were
allowed to acclimatize for at least one week prior the start
of the experimental procedure. They were randomized to
be fed for 5 weeks with either a control diet (C), a diet sup-
plemented with n-3 or n-6 PUFAs. Tap water and steri-
lized food were continuously available throughout the
study. The three formulations used are identical to the
AIN-93G [22] except that the soybean oil has been
replaced by three isocaloric and iso-fat content mixtures
(Table 1). Diet 1 is dominated by EPA and contains also
lower amounts of other n-3 PUFAs (ALA, STA, DHA)
while diet 2 is dominated by arachidonic acid (AA) (n-6
PUFAs). This study is a subset of the mice used in a recent
publication [23]. All procedures were in accordance with
the French Guide for the Care and Use of Laboratory Ani-
mals and with the guidelines of the European Union.Respiratory Research 2007, 8:39 http://respiratory-research.com/content/8/1/39
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Quantitative real-time PCR
Primer and TaqMan probe sequences were selected using
the Primer3 Output program Technology [24] from the
Massachusetts Institute of Technology. Primers and
probes (Table 2) have been chosen within the 3'-end of
mouse Muc cDNAs. To avoid amplification of contami-
nating genomic DNA, primers and/or the probes have
been designed on different exons or overlap exon-exon
junctions. To quantify mucin expression obtained by real-
time PCR, we used the standard curve method. The 18s
rRNA was chosen as an internal positive control. For each
mucin studied and for the 18s gene, reverse-transcribed
RNA extracted from mouse lung was amplified (see
below) and amplification products were cloned into the
3957-bp pCR4-TOPO vector (Invitrogen, France). Isola-
tion of plasmid DNA was carried out with the QIAprep
Spin Miniprep Kit (Qiagen). Positive clones were recon-
firmed by digestion with the EcoRI restriction enzyme and
inserts sequenced on both strands on Licor 4000 using
universal oligonucleotides. Serial dilutions of each Qia-
gen-purified plasmid with the cDNA insert were prepared
and DNA concentrations measured using the spec-
trofluorometer TD-360 (Fisher-Bioblock, France) and the
Hoechst 33258 dye. Serial dilutions of plasmid cDNAs
were amplified by qPCR in duplicate reactions, and stand-
ard curves were created by plotting the log of the input
plasmid cDNA quantity (ng) versus cycle threshold (Ct)
values for Muc4, Muc5ac, Muc5b and the 18s (Figure 1)
allowing to determine the copy number for each sample.
Preparation of the bacterial inoculum
The methodology was adapted from Cash et al. [25].
Briefly, P. aeruginosa (PAO1 strain) was incubated in 125
ml of tryptic soy broth at 37°C in a rotating shaking water
bath for 8 hours. The culture was then washed twice, and
resuspended in phosphate-buffered saline. The resulting
bacterial suspension was 1 × 109 CFU/ml. A sample of 1
mL of this suspension was mixed in agarose and mineral
oil (Sigma Diagnoses, St Louis, USA) at 56°C. The result-
ing oil-agarose emulsion was cooled to obtain agar beads.
Dilutions of the final suspension were cultured to deter-
mine the CFU of the final inoculum. Thirty mice (10 per
group) were inoculated per batch of agarose beads.
Experimental infection
Mice were anesthetized with sevoflurane (Sevorane™,
Abbott, UK), and placed in dorsal recumbency. Transtra-
cheal insertion of a 24-G animal feeding needle was used
to instill 60 μL of a 1:4 dilution of the agarose beads (2 ×
105 CFU/mouse). The mice were then allowed to recover.
The inoculation of mice is a critical step [26] and for a bet-
ter reliability a single operator conducted it. After instilla-
tion, mice were observed daily for clinical signs, such as
posture and ambulation. Two experimentally infected
mice were killed before the end of the experiment due to
their poor ambulation and visual sign of painful posture.
A few other infected mice died during the night and their
carcass eliminated whereas no mice inoculated with ster-
ile beads died.
Quantitative bacteriology
All mice were sacrificed using carbon dioxide followed by
cervical dislocation. The lungs were excised aseptically on
the first, the fourth or the seventh day after the inocula-
tion or just after 5 weeks of diet (control mice, day 0).
These lungs were then homogenized in PBS buffer, and
the samples were cultured quantitatively by serial dilution
on BCP agar plates (Biomerieux laboratories, Lyon,
France). The plates were incubated at 37°C and P. aerugi-
nosa colonies were counted after 24 h.
Expression of Muc genes
Uninfected and PAO1 instilled mice were sacrificed after
1, 4, or 7 days post- infection by cervical dislocation. The
lungs were collected, washed into sterile PBS, rapidly fro-
zen in liquid nitrogen and stored at -80°C until RNA
extraction. Total RNA was extracted using TriReagent
(Molecular Research Center, Inc., Euromedex, France) fol-
Table 1: Composition in fatty acids of the three diets (mg/100 mg of FA)
Group ω3 ω6c o n t r o l
Fatty acid
S-FA 11.7 25.9 31.3
MUFA 52.0 42.0 49.9
ALA 18:3n-3 3.7 3.1 3.2
STA 18:4n-3 0.8 < 0.1 < 0.1
EPA 20:5n-3 12.7 < 0.1 < 0.1
DHA 22:6n-3 3.9 0.1 < 0.1
LA 18:2n-6 14.2 12.8 14.5
GLA 18:3n-6 < 0.1 1.0 < 0.1
AA 20:4n-6 0.7 13.5 0.1
abbreviations : FA, fatty acids; S-FA, total saturated FA; MUFA, mono-unsaturated FA; ALA, alpha-linolenic acid; STA, stearidonic acid; EPA, 
eicosapentaenoic acid; DHA, docosahexaenoic acid; LA, linoleic acid; GLA, gamma-linolenic acid; AA, arachidonic acidRespiratory Research 2007, 8:39 http://respiratory-research.com/content/8/1/39
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lowing manufacturer's protocol followed by precipitation
in ethanol and resuspension in ribonuclease-free water.
Single-stranded cDNA was generated from 2 μg of total
RNA using the First -Strand cDNA Synthesis Kit (Clontech,
Ozyme, France) and random hexamers according to the
manufacturer's instructions. The 20 μL of cDNA was
diluted with 80 μL of DEPC-water. Duplex PCR amplifica-
tion was carried out in 25-μL reaction volumes containing
2 μL of the first strand cDNA, 10 pmol of each primer for
a given mucin studied, 5 pmol of each mucin probe and
2× TaqMan Universal PCR Master Mix (Applied Biosys-
tems) containing 1 pmol of the 18s-primers (sense and
antisense), 5 pmol of the 18s-probe (5' Vic reporter dye),
5,6-carboxy-x-rhodamine (ROX), the Taq DNA polymer-
ase and the requisite buffers. Probes (Applied Biosystems,
France) were labeled with 6-carboxy-fluorescein phos-
phoramidite (FAM) at the 5' end and as quencher 6-car-
boxy-tetramethyl-rhodamine (TAMRA) at the 3' end. The
fluorescence intensity of the reporter label was normal-
ized to the rhodamine derivative ROX as a passive refer-
ence label present in the buffer solution. The system
generated a kinetic amplification plot based upon the nor-
malized fluorescence. Amplifications were performed on
the ABI Prism 7700 Sequence Detection System (Applied
Biosystems). Quantitative analysis was conducted using
an ABI7700 Real-Time Detection System. The PCR reac-
tion ran for 45 cycles of a two-step PCR amplification
(95°C for 10 minutes and 60°C for 1 minute). All reac-
tions were run in triplicate. Negative controls were carried
out with water instead of cDNA.
Data and statistical analysis
cDNA copies of Muc transcripts were adjusted with the
number of cDNA copies for the 18s and Log transformed
values were represented (Figures 2, 3, 4). For PAO1-inoc-
ulated experiment (Figure 4), each measured value has
been divided by the median of the counterpart group of
mice inoculated with sterile agarose beads. Comparisons
were analyzed using the statistical package StatXact® 6.0
(Cytel Studio) for exact nonparametric inference. Wil-
coxon-Mann-Whitney one-sided p-values were calculated
to compare differences between groups (between diets for
each day and between days for each diet) and given in Fig-
ures 3, 4. P values are given in 2 × 2 tables on figures 3 and
4. Correlations between variables were calculated by using
Spearman's rank correlation tests (rs) with the Monte
Carlo option. A p-value ≤ 0.05 was considered statistically
significant.
Results
Mice were fed for 5 weeks prior P. aeruginosa (PAO1)
infection with either a control diet (C) or a diet enriched
with n-3 PUFAs or n-6 PUFAs (Table 1). This model mim-
ics chronic lung infection in mice [25-28] as they lost
Table 2: Primer and probe sequences for murine mucins
Mucin Sequence (5'-3') Product length
Muc4 FW GTCCACTTCTTCCCCATCTC
RV GTAGCCTTTGTAGCCATCACAT
PB CCAGGACCAGATGGCTCTGAACCT 102 bp
Muc5b FW GCACGTAAATGCGACTGTCT
RV ATGGACCTTGCTCTCCTGAC
PB TATCCAAGTACTCCATGGAGGCCC 133 bp
Muc5ac FW TCCCTTACCTAACCAGCAGAA
RV GGGAGTACATGGAGATGCTGT
PB GAGGGCCCAGTGAGCATCTCCTACT 118 bp
FW, forward primer; RV, reverse primer; PB, TaqMan probe dual-labeled with 5'FAM and 3'TAMRA.
Graphical representation of linear regression analyses to vali- date the quantitative real-time PCR (qPCR) assay Figure 1
Graphical representation of linear regression analyses to vali-
date the quantitative real-time PCR (qPCR) assay. Dilutions 
of plasmid cDNA were amplified by qPCR in duplicate reac-
tions, and standard curves were created by plotting the cycle 
threshold (Ct) values versus DNA quantity (Log quantity) in 
ng for 18s, Muc4, Muc5ac and Muc5b.Respiratory Research 2007, 8:39 http://respiratory-research.com/content/8/1/39
Page 5 of 11
(page number not for citation purposes)
weight after infection and bacteria could still be recovered
at the termination of the study [23]. Bacterial clearance
was analyzed over the 7 days of the experiment. The
number of bacteria dropped over time in each group, and
a comparable pattern was observed for each diet with no
difference between the three groups [23].
To study mucin gene expression, we designed a fluores-
cence based PCR assay to determine an exact and absolute
quantification of the mouse Muc5b, Muc5ac  and Muc4
RNAs allowing comparisons of expression levels between
the three different Muc genes. The housekeeping gene 18s
was used as an internal positive control and to normalize
each Muc gene expression level. The cDNA amplification
products of mouse Muc4 (102 bp ; table 2), Muc5b (133
bp),  Muc5ac  (118 bp) and mouse 18s  (187 bp) were
cloned into the pCR4 plasmid vector. Serial dilutions of
these cDNA plasmids were used to establish standard
curves, and cycle threshold (Ct) values were determined to
be between 8 and 13 (Figure 1). Ct values represent the
number of amplification cycles required to produce a spe-
cific amount of fluorescence during the exponential phase
of the quantitative PCR. Consequently, the higher the Ct
value, the lower the concentration of the template being
amplified. Ct values increased linearly with decreasing
input cDNA plasmids. The average r2 values for the 18s
and the Muc genes assayed were greater than 0.98 (Figure
1). Efficiency of our Muc PCR assays varied (mean slope)
from -3.10 to -3.27 while the efficiency of the commer-
cially 18s was -2.47.
We performed qPCR on 15 mice that were non-inoculated
(day 0, 5 mice/group), 45 inoculated with sterile beads
and sacrificed at days 1, 4 and 7 (5 mice/group/day) and
on infected lung tissues from mice of the n-3 PUFAs, con-
trol and n-6 PUFAs diet groups that were killed at days 1
(5, 6 and 6 mice, respectively), 4 (6 mice/group) or 7 (11,
6 and 3 mice, respectively). Figure 2 shows the relative
copy numbers of Muc4, Muc5b and Muc5ac normalized
with the 18s for mice fed with the three diets. The expres-
sion level of Muc4 in lung of healthy mice was higher than
the expression levels of both Muc5b and Muc5ac RNAs.
Medians of normalized Muc genes for control groups were
1.8 × 10-3, 2 × 10-11 and 2 × 10-6 for Muc4, Muc5b and
Muc5ac, respectively, pointing out the high level of Muc4
in comparison with the two secreted gel-forming mucins.
We did not observe any significant impact of the diet on
the regulation of the three Muc genes studied.
Inoculation with sterile agarose beads induced a signifi-
cant downregulation of Muc4  and an upregulation of
Muc5b (Figure 3). At day 7, the level of Muc4 increased
towards its baseline level (day 0). For each day, the diet
has no impact on the two mucins gene expression except
at day 7 on the Muc5b transcripts where the level of expres-
sion is n-3 < n-6 (p < 0.05). Concerning the Muc5ac gene,
levels of the RNA transcript between the groups were sim-
ilar over time with the exception for the n-6 PUFAs treated
group between days 0/4 and 0/7 where the AA-enriched
diet played an enhanced effect. In conclusion, the diet has
almost no effect on mucin gene expression of mice inocu-
lated with sterile agarose beads.
We next examined whether diet had an impact on Pseu-
domonas-infected mice. For each group at each day, the
Log10 transformed value measured was normalized with
the mucin median value of the corresponding group
where mice were inoculated with sterile agarose beads.
Membrane-bound Muc4 expression decreased over time
(Figure 4). On the fourth day after infection, the n-3
PUFAs enriched diet has a high suppressive effect on the
level expression of Muc4 (p < 0.005). Muc5b expression
increased significantly for the n-3 PUFAs treated group
between days 1 and 4. The expression levels tend to go
down at day 7 with a statistically decrease for the control
diet group. At days 1 and 4, the peak of expression of the
large secreted gel-forming mucin Muc5b was higher for the
control group diet in comparison with the n-3 PUFAS
treated group suggesting a suppressive effect of n-3 PUFAs
on inoculated mice. P. aeruginosa lung infection did not
appear to impact Muc5ac expression over time, regardless
of diet. Level of expression is higher at day 1 for the n-3
PUFAs treated group comparing to the two other groups.
This peak is followed by a decrease at day 4. Additionally,
we noticed a large dispersion of samples of the n-3 PUFAs
treated group for the three Mucs studied at day 7.
Gene expression analysis in lung by absolute qPCR of mouse  Muc4, Muc5ac and Muc5b transcripts normalized with the  18s Figure 2
Gene expression analysis in lung by absolute qPCR of mouse 
Muc4, Muc5ac and Muc5b transcripts normalized with the 
18s. Five healthy mice fed with the control diet for 5 weeks 
were used in each group. Ratios between the absolute 
amounts of the three Muc copy numbers and the 18s copy 
number is given in Log10 (Muc/18s)+11 due to the high differ-
ence between the Muc4 level expression and the two other 
Mucs gene expression levels.Respiratory Research 2007, 8:39 http://respiratory-research.com/content/8/1/39
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Effect of the diet on the mouse Muc4, Muc5b and Muc5ac gene expressions of mice inoculated with sterile agarose beads Figure 3
Effect of the diet on the mouse Muc4, Muc5b and Muc5ac gene expressions of mice inoculated with sterile agarose beads. Val-
ues represent the Log10 copy number of each Muc transcript normalized with the 18s (log(Muc/18s))+11. Exact P-values were 
calculated to compare the effect between days for a given diet (ω3: n-3 PUFA treated group; C: control diet group; ω6: n-6 
PUFA treated group) or between diets for a given day. Significant P-values are given in 2 × 2 tables.Respiratory Research 2007, 8:39 http://respiratory-research.com/content/8/1/39
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Suppressive effect of an n-3 PUFAs enriched diet on the Muc gene expression of mice infected with P. aeruginosa Figure 4
Suppressive effect of an n-3 PUFAs enriched diet on the Muc gene expression of mice infected with P. aeruginosa. Values repre-
sent 6+log [(Muc of infected lung/18s of infected lung)/median(Muc of sterile beads/18s of sterile beads)]. Exact P-values were 
calculated to compare the effect between days for a given diet (ω3: n-3 PUFA treated group; C: control diet group; ω6: n-6 
PUFA treated group) or between diets for a given day. Significant P-values are given in 2 × 2 tables.Respiratory Research 2007, 8:39 http://respiratory-research.com/content/8/1/39
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Associations between the three-studied Muc gene expres-
sions were assessed using Spearman's s rank correlation
coefficient. There was no statistically significant associa-
tion between Muc4 and either Muc5ac or Muc5b at day 0
and at day 1. However, Spearman's rank correlation indi-
cated a strong positive correlation at day 4 (rs = 0.67 ; p <
0.004 and rs = 0.84 ; p < 0.0001), for Muc4/5ac and Muc4/
5b, respectively and at day 7 (rs = 0.9 ; p < 0.0001 and rs =
0.76 ; p < 0.0001) for Muc4/5ac and Muc4/5b, respectively.
Concerning Muc5ac and Muc5b, the two gene expressions
were statistically correlated at days 1 and 7 (rs = -0.57 ; p <
0.03 and rs = 0.81 ; p < 0.0001, respectively). Spearman's
rank-order correlation coefficient did not show any rela-
tionships between the bacteria number and the three Muc
genes except for Muc4 at day 7 (rs = -0.48 ; p < 0.04).
Discussion
Mucus hypersecretion, viscoelastic alteration and mucin
overproduction are the hallmarks of many lung diseases
such as CF [9,17,29] where P. aeruginosa is the principal
pathogenic microorganism. The properties of the mucus
layer are dictated by the water content and the mucin layer
composition. MUC5AC, MUC5B and MUC4, which are
conserved mucins between human and rodent [30,31],
are three predominant large mucins expressed in the lung.
Many studies have focused on MUC5AC and MUC2 regu-
lation in airway diseases using mainly airway cell and
explant cultures [32-34] while the expression of the oligo-
meric mucin MUC5B and the membrane-bound mucin
MUC4 have not yet been investigated. However, biochem-
ical studies on human samples have shown that the aber-
rant physical properties of the mucus gel obstructing the
airways from an individual that died in status asthmaticus
are due to MUC5B and not MUC5AC [35,36]. Many, if not
all, investigations that used human secretions encoun-
tered biased results due to the false status of the patient
studied, non-controlled environmental parameters or dif-
ficulties to analyze in vivo mucins production pointing out
the benefit of animal models in CF studies. Using a precise
and reliable assay we (i) determined here the relative
expression of lung mucins of healthy mice, mice inocu-
lated with sterile agarose beads and mice infected with P.
aeruginosa and (ii) examined the effects of a diet enriched
either with n-3 PUFAs or n-6 PUFAs on mucin expression
following experimental mouse lung inoculation.
The model of infection we used does not mimic perfectly
a chronic lung infection, as the number of bacteria
declined over time and several lung mice that were inocu-
lated with PA01 were culture-negative at day 7. However,
this model is still the best one available in mice [27,28]. A
single operator trained for delivering a uniformity of bead
preparations from experiment to experiment and for inoc-
ulating mice performed these two steps in order to mini-
mize caveats associated with this model (e.g., variability
inherent to operator for the instillation procedure, in
making agarose beads [26]).
To follow the mouse Muc gene expression that likely
reflects protein synthesis [5,37,38], we designed an abso-
lute PCR quantification assay instead of the often-used
comparative Ct method. One advantage of the absolute
qPCR is that the efficiency of the housekeeping gene used
as an internal reference and the target Muc genes must not
be necessary identical. Furthermore, absolute qPCR
allows a more precise and sensitive RNA quantification
with reliability between different laboratories. In our
mouse model, we followed Muc5b,  Muc5ac  and  Muc4
while the Muc2  messenger was barely undetectable in
lung tissue and did not show any variation prior or after
instillation by sterile or PAO1-laden agarose beads (data
not shown). This study showed for the first time that diet
has an impact and could modulate lung mucin gene
expression in an in vivo model of bacterial infection.
As it is well-known, rodent models only partially resemble
the native architecture and abundance of submucosal
glands in the human airways [39], it is therefore not sur-
prising that Muc5b is almost undetectable using qPCR in
the lungs of healthy mice. In human, it has been reported
that MUC5AC expression, measured using real-time RT-
PCR, is much higher than both MUC5B and MUC4 in
homogenates of endobronchial biopsies from healthy
subjects or subjects with asthma [40]. Here we showed in
mouse lung that Muc4 is highly expressed in comparison
to Muc5b and Muc5ac. This could be due to the species
studied and/or the "healthy" status of the human biopsies
used by others and/or the RT-PCR quantification strategy.
Moreover, we chose an absolute quantification method
using primers directed at the 3'-end of the Muc genes with
oligonucleotides belonging to different exons while in the
previous work authors quantified MUC4 expression using
a relative qPCR strategy with oligonucleotides chosen
within exon 2 of the gene.
Yanagihara et al. showed that intratracheal injection of
100 μg of P. aeruginosa lipopolysaccharide (LPS) induced
mucus cell metaplasia. Northern blot analysis using 3
mice showed an increase of the Muc5ac messenger with a
peak at day 4 followed by a decrease of Muc5ac RNA [41].
In this present study, we did not observe major modifica-
tion in the Muc5ac expression with the exception of an
upregulation at day 7 for the n-6 PUFAs treated group
inoculated with sterile beads (Figure 3).
PAO1 lung inoculation induced two opposite expression
patterns of Muc5b and Muc4: Muc5b is highly upregulated
with a peak at day 4 showing a suppressive effect of n-3
PUFAs on the Muc5b response to the infection while Muc4
expression decreased to the lowest level at days 1 or 4 forRespiratory Research 2007, 8:39 http://respiratory-research.com/content/8/1/39
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sterile beads and at day 7 for Pseudomonas-laden agarose
beads. In parallel with the bacterial clearance by ciliary
transport, expression of Muc5b decreased almost to base-
line levels on day 7. The increase of Muc5b messenger may
reflect either a transdifferentiation of ciliated cells to a
secretory phenotype or differentiation of hypothetical
progenitor cells [38].
It is now well known that consumption of fish oil contain-
ing n-3 PUFAs reduces the risk of many human diseases
[42]. Dietary lipid manipulation may affect different
immune parameters and the immune modulation
induced by dietary fatty acids may be applied by the
improvement of inflammatory disorders. A dietary
immune regulation with a defined blend of specific long-
chain polyunsaturated fatty acid species should represent
an interesting alternative to immune suppressive mole-
cules, like corticosteroids, which often causes side-effects.
Compared to other studies that used fish oil supplemen-
tation or uncontrolled vegetable oil extractions, we used
two fat isocaloric and isofat content blends. One is domi-
nated by eicosapentanoic acid (EPA) -but contained other
n-3 PUFAs- that act as a competitive inhibitor of AA con-
version to the pro-inflammatory key mediators PGE2 and
LTB4 while the other diet is dominated by AA, which gives
rise to PGE2 and LTB4 (reviewed by James et al. [3]). On
the other hand, PUFAs are also candidates to directly
influence gene expression that is connected to diseases
and then to enhance epithelial protection during inflam-
mation and/or pathogenic bacterial colonization. PUFAs
integrated into cellular membranes could also influence
cell function and membrane integrity as DHA and AA
compete for the same elongation and desaturation
enzymes and for the site of esterification of phospholip-
ids. The switching of AA by DHA leads to a change in reg-
ulatory fluidity and membrane trafficking [43,44].
The present study shows that dietary PUFAs did not influ-
ence mucin gene expression in the lungs of healthy mice
after 5 weeks of diet (control mice and mice inoculated
with sterile beads). As the three experimental diets only
differed in their content of PUFAs, differences in fatty
acids are most likely responsible for the regulation of lung
mRNA transcripts of mucins after infection by P. aerugi-
nosa in agreement with Spearman's rank correlation. The
regulation is modulated by the PUFAs intake with a sup-
pressive effect of n-3 PUFAs on mucin upregulation and/
or possibly an enhanced effect on the same Muc genes by
n-6 PUFAs. This work is a part of a larger study and it
should be noted that mice exposed to high n-3 PUFAs
intakes and infected by P. aeruginosa exhibited a lower
mortality than mice from the control group and mice fed
with the diet rich in n-6 PUFAs [23] at day 4 after infection
while survival rate of mice inoculated with sterile agarose
beads was 100% at day 7 regardless of diet. One limit of
our study is that a few mice inoculated with PAO1 died
before day 4 (more in the control group and n-6 treated
PUFAS group compared to n-3 PUFAs treated group) and
were therefore not studied rending interpretations diffi-
cult for day 1.
Taken together, these data suggest that dietary intake of n-
3 PUFAs reduces the lung damage by P. aeruginosa. Nieto
et al. draw a similar conclusion about n-3 PUFAs and
intestinal damages in rats with experimental ulcerative
colitis where n-6 PUFAs enhanced tissue responsiveness
to cytokines and n-3 PUFAs had opposite effects [5]. This
suggests that overproduction of large mucins that likely
leads to airway mucus obstruction in Pseudomonas aerugi-
nosa chronic pneumonia may be counterbalanced by a n-
3 PUFAs enriched diet. Further studies will be needed to
confirm the relationship between mucin expression levels
and mucus obstruction and to determine if the beneficial
suppressive effects of dietary n-3 PUFAs on mucin expres-
sion used a direct or pro-inflammatory cytokine-depend-
ent mechanism.
Conclusion
In summary, lung infection by P. aeruginosa induced a dis-
regulation of the large mucins Muc5b and Muc4. These
modifications of mucin expression are modulated by die-
tary long-chain fatty acids with a beneficial suppressive
effect of n-3 PUFAs confirming our first hypothesis. This
strongly supports that malnutrition can compromise pul-
monary defenses against P. aeruginosa colonization [45].
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